Board of Directors

The founder of the company, Georges Charpak was awarded the 1992 Nobel Prize for his discoveries in particle detection for high energy physics. Besides his involvement with scientific instrumentation, Georges is very active on matters such as nuclear related risks and science education, and has authored several general public books. He is a member of the board of two medtech companies.

Bruno holds a Master of Science in Biotechnologies and has been in the biotech business for 15 years. After spending some years in technology transfer in France, he held a position as a Research Associate and Business Analyst in a consulting firm of Chicago, USA. Bruno came back to France in 2001 to participate to the launch of a biotechnology incubator and then took a position of Business Development Manager during four years at Cellectis, biotech start-up specialized in genome engineering and now quoted on the AlterNext. Then Bruno spent two years as Director, Business Development, at Mauna Kea Technologies, Medtech start-up focused on in-vivo microscopic imaging.

Raphaël Wisniewski represents Edmond de Rothschild Investment Partners at the Board of the company as well as that of several other healthcare companies: Androclus Therapeutics SpA, OncoMethylome Sciences SA, Novagali Pharma SA, Nautilus Biotech SA, Pamgene BV and Theraptosis SA.Prior to joining EDRIP Raphaël spent several years in investment banking at Goldman Sachs and Salomon Smith Barney in London advising healthcare sector clients on corporate finance matters

Olivier Denigot represents Nord Europe Private Equity at Biospace Lab Board of Directors. Olivier participates in several other boards of companies in the IT and healthcare areas.

Arnaud Houette, CEO of Capsule Technologie, the world’s leading provider of solutions for medical device data integration, is an independent Board Member.